Ryzodeg
(degludec/insulin aspart) Novo Nordisk
Composition:
Indication:
Drug information updated in ‘The Pace’, including formulation, indication, administration and/or presentation being registered or available in Hong Kong within one year prior to the published date is regarded as new.
The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.